Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'Characteristics and durability of immune response to fractional dose compared to standard dose Yellow Fever vaccine: a pilot open-label 1:1 randomized non-inferiority/estimation trial in adults in Singapore'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Dr Sapna P. Sadarangani
Published by HT Digital Content Services with permission from Health Daily Digest....